Moreover, the scientific community has recently identified that the lung cancer population is at higher risk of contracting COVID-19 and that the aberrant expression of ACE2 in lung carcinoma renders the patients more susceptible to COVID-19 (105, 106). The gene discussed is ACE2; the disease is COVID-19.